Inventor · disambiguated record
Gary Tollefson
Also filed as: TOLLEFSON GARY · TOLLEFSON GARY D · TOLLEFSON GARY DENNIS
20 granted patents·34 pending applications·507 citations·filing 1995–2024
96Inventor score
Files withOREXIGEN THERAPEUTICS INC25NALPROPION PHARMACEUTICALS LLC7LILLY CO ELI6NALPROPION PHARMACEUTICALS INC4MCKINNEY ANTHONY3
Top patents by PatentIndex Score
54 records- 0197US8088786B2Layered pharmaceutical formulationsMCKINNEY ANTHONY·Filed 2007·Granted Jan 3, 2012·64 cites·6 claims
- 0296US9125868B2Methods for administering weight loss medicationsOREXIGEN THERAPEUTICS INC·Filed 2014·Granted Sep 8, 2015·40 cites·17 claims
- 0396US8722085B2Methods for administering weight loss medicationsMCKINNEY ANTHONY·Filed 2010·Granted May 13, 2014·45 cites·17 claims
- 0495US12048769B2Methods for administering weight loss medicationsNALPROPION PHARMACEUTICALS LLC·Filed 2020·Granted Jul 30, 2024·3 cites·20 claims
- 0594US9107837B2Sustained release formulation of naltrexoneOREXIGEN THERAPEUTICS INC·Filed 2014·Granted Aug 18, 2015·13 cites·17 claims
- 0694US8318788B2Layered pharmaceutical formulationsMCKINNEY ANTHONY·Filed 2011·Granted Nov 27, 2012·25 cites·20 claims
- 0792US8916195B2Sustained release formulation of naltrexoneMCKINNEY ANTHONY A·Filed 2007·Granted Dec 23, 2014·23 cites·15 claims
- 0890US11033543B2Methods of providing weight loss therapy in patients with major depressionNALPROPION PHARMACEUTICALS LLC·Filed 2019·Granted Jun 15, 2021·3 cites·19 claims
- 0989US10307376B2Methods for administering weight loss medicationsNALPROPION PHARMACEUTICALS INC·Filed 2018·Granted Jun 4, 2019·5 cites·20 claims
- 1089US8815889B2Compositions and methods for increasing insulin sensitivityCOWLEY MICHAEL A·Filed 2006·Granted Aug 26, 2014·18 cites·31 claims
- 1189US5658590ATreatment of attention-deficit/hyperactivity disorderLILLY CO ELI·Filed 1995·Granted Aug 19, 1997·95 cites·16 claims
- 1288US11324741B2Methods for treating visceral fat conditionsOREXIGEN THERAPEUTICS INC·Filed 2017·Granted May 10, 2022·2 cites·18 claims
- 1388US9457005B2Compositions and methods for increasing insulin sensitivityOREXIGEN THERAPEUTICS INC·Filed 2014·Granted Oct 4, 2016·9 cites·17 claims
- 1487US6960577B2Combination therapy for treatment of refractory depressionLILLY CO ELI·Filed 2002·Granted Nov 1, 2005·20 cites·4 claims
- 1587US6147072ACombination therapy for treatment of psychosesLILLY CO ELI·Filed 1997·Granted Nov 14, 2000·79 cites·22 claims
- 1686US9248123B2Methods of providing weight loss therapy in patients with major depressionDUNAYEVICH EDUARDO·Filed 2011·Granted Feb 2, 2016·12 cites·18 claims
- 1786US2024366513A1Methods For Administering Weight Loss MedicationsNALPROPION PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 1885US10322121B2Methods of providing weight loss therapy in patients with major depressionOREXIGEN THERAPEUTICS INC·Filed 2016·Granted Jun 18, 2019·4 cites·17 claims
- 1984US2023301922A1Layered Pharmaceutical FormulationsNALPROPION PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 2076US2022257591A1Methods for Treating Visceral Fat ConditionsNalpropioin Pharmaceuticals LLC·Filed 2022·Application pending·0 cites
- 2173US2021346469A1Compositions and Methods for Increasing Insulin SensitivityNALPROPION PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 2273US2021267968A1Compositions And Methods For Reducing Food CravingsNALPROPION PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 2372US2019183883A1Sustained Release Formulation Of NaltrexoneNALPROPION PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2471US2021299119A1Methods Of Providing Weight Loss Therapy In Patients With Major DepressionNALPROPION PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 2570US2014309252A1Compositions and methods for reducing food cravingsOREXIGEN THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 2668US2019282503A1Methods For Administering Weight Loss MedicationsNALPROPION PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2766US2011144145A1Methods for treating visceral fat conditionsOREXIGEN THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 2866US2007129283A1Compositions and methods for reducing food cravingsMCKINNEY ANTHONY A·Filed 2006·Application pending·0 cites
- 2965US2015164806A1Layered pharmaceutical formulationsOREXIGEN THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3065US2008110792A1Methods for administering weight loss medicationsOREXIGEN THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 3165US2017014404A1Sustained release formulation of naltrexoneOREXIGEN THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3263US2015119417A1Methods for treating visceral fat conditionsOREXIGEN THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3363US2016158225A1Sustained release formulation of naltrexoneOREXIGEN THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3463US2019231852A1Compositions And Methods For Increasing Insulin SensitivityNALPROPION PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3562US2016158221A1Sustained release formulation of naltrexoneOREXIGEN THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3661US2011028505A1Compositions and methods for reducing food cravingsOREXIGEN THERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 3761US2013177602A1Layered pharmaceutical formulationsOREXIGEN THERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 3859US6159963AMethod for treating substance abuseLILLY CO ELI·Filed 1997·Granted Dec 12, 2000·20 cites·38 claims
- 3959US2016193152A1Methods for administering weight loss medicationsOREXIGEN THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 4058US2016338965A1Layered pharmaceutical formulationsOREXIGEN THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4158US2017312269A1Compositions and methods for reducing food cravingsOREXIGEN THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4257US2017020990A1Compositions and methods for increasing insulin sensitivityOREXIGEN THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4356US2007148237A1Sustained-release formulation of zonisamideOREXIGEN THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 4456US2007185084A1Compositions of an anticonvulsant and methods of using the same for reversing weight gainOREXIGEN THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 4556US2008214592A1Methods of treating anxiety disordersOREXIGEN THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 4655US2014080857A1Methods for prophylatic appetite suppressionOREXIGEN THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 4754US5696168ATreatment of attention-deficit/hyperactivity disorderLILLY CO ELI·Filed 1996·Granted Dec 9, 1997·16 cites·14 claims
- 4852US2007179168A1Methods of treating anxiety disordersOREXIGEN THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 4952US2007117827A1Compositions for affecting weight lossTOLLEFSON GARY·Filed 2006·Application pending·0 cites
- 5050US5958921AMethod for treating depression with olanzapineLILLY CO ELI·Filed 1996·Granted Sep 28, 1999·11 cites·13 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →